4//SEC Filing
RUXIN MICHAEL I 4
Accession 0001213900-18-012382
CIK 0001451929other
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 6:43 PM ET
Size
6.1 KB
Accession
0001213900-18-012382
Insider Transaction Report
Form 4
RUXIN MICHAEL I
Chief Executive Officer
Transactions
- Award
Series A Preferred Stock
2018-08-23$1.00/sh+25,000$25,000→ 25,000 total→ Common Stock
Footnotes (1)
- [F1]The Reporting Person purchased the Series A Preferred Stock from the Company on August 23, 2018. The Series A Preferred Stock has no expiration date and upon consummation of a reverse stock split of the Issuer's common stock such that after consummation of such reverse stock split there are approximately 15,000,000 shares of the Issuer's common stock outstanding, the holders shall take all necessary steps with the Issuer to exchange all outstanding shares of Series A Preferred Stock into shares of the Issuer's common stock at a rate to be agreed upon between the parties. The holders of Series A Preferred Stock collectively shall always constitute 50.1% of the voting power of the Issuer.
Documents
Issuer
Avant Diagnostics, Inc
CIK 0001451929
Entity typeother
Related Parties
1- filerCIK 0001249549
Filing Metadata
- Form type
- 4
- Filed
- Sep 10, 8:00 PM ET
- Accepted
- Sep 11, 6:43 PM ET
- Size
- 6.1 KB